GGrantIndex
← Search

Flow Cytometry Facility

$122,587P30FY2015CANIH

Northwestern University At Chicago, Evanston IL

Investigators

Linked publications, trials & patents

Trial NCT07639528Trial NCT07594626Trial NCT07594548Trial NCT07290543Trial NCT07261657Trial NCT07178301Trial NCT07169617Trial NCT07050186Trial NCT07042919Trial NCT06959641Trial NCT06813898Trial NCT06723457Trial NCT06630416Trial NCT06571734Trial NCT06499870Trial NCT06410248Trial NCT06327477Trial NCT06247540Trial NCT06244004Trial NCT06242834Trial NCT06184750Trial NCT06164275Trial NCT06137651Trial NCT06062498Trial NCT06060587Trial NCT06022822Trial NCT05879250Trial NCT05852041Trial NCT05802186Trial NCT05744739Trial NCT05733000Trial NCT05620771Trial NCT05576896Trial NCT05545150Trial NCT05453799Trial NCT05419011Trial NCT05411107Trial NCT05236036Trial NCT05202782Trial NCT05093387Trial NCT04931017Trial NCT04910425Trial NCT04795869Trial NCT04767984Trial NCT04753216Trial NCT04576104Trial NCT04550481Trial NCT04250051Trial NCT04227028Trial NCT04200443Trial NCT04049227Trial NCT04047706Trial NCT04033432Trial NCT04009044Trial NCT03854474Trial NCT03812562Trial NCT03742258Trial NCT03723915Trial NCT03704714Trial NCT03513484Trial NCT03317405Trial NCT03278925Trial NCT03226249Trial NCT03213041Trial NCT03146650Trial NCT03077828Trial NCT03070002Trial NCT03061188Trial NCT03048500Trial NCT03044730Trial NCT03036930Trial NCT03020017Trial NCT02993159Trial NCT02968810Trial NCT02965703Trial NCT02901899Trial NCT02892734Trial NCT02871323Trial NCT02861040Trial NCT02847559Trial NCT02837029Trial NCT02819804Trial NCT02808143Trial NCT02805868Trial NCT02794883Trial NCT02774681Trial NCT02743364Trial NCT02720484Trial NCT02694809Trial NCT02536794Trial NCT02530619Trial NCT02530502Trial NCT02530125Trial NCT02481310Trial NCT02365480Trial NCT02357810Trial NCT02314156Trial NCT02242097Trial NCT02237183Trial NCT02232516

Abstract

PROJECT SUMMARY (See instructions): The Robert H. Lurie Comprehensive Cancer Center Flow Cytometry Core Facility provides comprehensive flow cytometry and cell sorting services. The Flow Cytometry Core Facility serves investigators of the Cancer Center, Northwestern University Medical School, Northwestern University and other affiliated institutions by providing access to routine flow cytometry assays such as immunophenotyping and DNA analysis. However, the major mission of the facility is to provide the guidance, technical assistance, and equipment for investigators to utilize more complex multi-parametric, multi-laser measurements as well as cell sorting in their research regardless of their level of cytometry expertise. The Core Facility has an international reputation and extensive experience in developing and implementing complex multi-parametric assays with particular expertise in intracellular liable antigen detection such as phosphorylated protein epitopes. This level of expertise along with the equipment housed within the Core Facility permits implementation of most flow cytometry assays that have been published. Services provided by the facility extend from consultation on experimental design, sample preparation and data analysis to instrument operation and set-up for cell sorting and multi-laser operation. In addition, the Core Facility has an active program of assay development guided by the interests/needs of the investigators. Reflective of the facility's commitment to flow cytometry education/ training of the next generation of researchers, user training for operation of not only less complex analysis instruments but also the more complex analyzer and sorting instruments is offered. Thus, the Flow Cytometry Core Facility serves as a focus for individuals interested in cellular based measurements and cellular heterogeneity in disease providing critical support for cancer related research within the institution. The Chicago campus facility includes three cell sorters; a 5 laser/15 parameter MoFlo high speed cell sorter (Beckman-Coulter. BC) along with two new Becton-Dickinson (BD) FACSAria 111 cell sorters, a 4 laser/13 parameter instrument and a 5 laser/17 parameter instrument housed in a Bio-containment hood and negative pressure room; and a 3 laser, 10 parameter FACSAria II (BD) on the Evanston campus. The Chicago campus facility also has three benchtop flow cytometry analyzers; a 6 laser/18 parameter FORTESSA (BD), a 3 laser/11 parameter Cyan (BC) and a single laser/six parameter XL (BC) with the Evanston facility having a 4 laser/13 parameter LSRII (BD). In addition, the Chicago facility has a ViCell cell counter/viability instrument (BC). The facility has multiple offline analysis workstations providing the components for post acquisition data analysis and graphics generation. The Core Facility is now heavily utilized by a wide number of investigators (148), approximately 62% of which are Cancer Center members who account for approximately 74% of core utilization.

View original record on NIH RePORTER →